I don't blame Al for not purchasing more shares. He has done his share of buying. I question why Matt, Hakken and the rest of the "executives" are not buying shares.
I hesitate to even say it but, his concerns were with Lung Cancer in prescribing it. This is just one awesome day....
Its not that I believe the perception isn't insurmountable. It just may be too much for this lack luster team of executives to manage.
SNY may be our only saving grace...... if they would ever come out and play.
He had never heard of Afrezza before. I am glad the education obstacle is being delt with head on by our awesome management team!!!
I personally, by my prodding and through my GF, have educated an ENDO to the existence of AFREZZA. I suggest everyone do the same. Not sure waiting on Matt to do it is the best path forward.
Are these guys actually willing to put in all the work to clear the land, till the soil, sew the seeds just to let it rot of the vine?
Al, Matt and Hakken are playing the fiddle while Rome burns to the ground.
I am not one to rant but the lack of leadership here is pathetic. THANK GOD SANIFI WILL BE SELLING THIS.
I am just waiting for a manufacturing SNAFU, but we wouldn't know anything about that would we? Since they have not even given one update on their progress.
VERY ANNOYED. Good news is they have finally gotten to me, and my tolerances are pretty standard. Lets hope this is the final capitulation and THIS IS THE BOTTOM.
The market will determine this as out management will do nothing but listen the the music.
While Rome burned to the ground.
I am still holding through this but I am disgusted by this companies paralysis in defending itself.
How about these guys show a bit of faith and resolve and buy some shares? So something to earn your greatly bloated and undeserved pay.
SNY could announce a tender offer that isn't yet settled allowing for a squeeze to occurr. Mann owns enough shares to control the upper price target (assuming he is allowed to do so). Shorts have 30% of the float owns 40% of outstanding shares. Tender offer of 15.00 a share squeeze to 35.00 settle at 22.50
My apologies but today we are trading almost in lockstep with the BIB index. Excluding the large red candlestick 150K this afternoon there really hasn't been anything suspicious.
WE NEED SOME NEWS!!!!! MANUFACTURING
One GSK study in Lung cancer and the other in melanoma
If you search SSX-2 only Baylor comes up.
If you go to clinical trials . gov the only studies that come up when you search PRAME tumor-associated antigen are sponsored by Baylor School of Medicin, GSK, MNKD and NCI.
Not sure if there is anything to read into that or not but that's what I found
150M is 6.25% of the total value of MNKD at its current 2.4B valuation.
150M in profit= 150M X 20 multiple (which we should but won't get) / 400M shares = 7.5 pps
There are those who are biased short and will say SNY didn't make a large investment in MNKD. I say B.S.
This is the equivalent of 630M in sales.
Correct clevans1. Though it is true that the experimental designs were deemed insufficient to include such claims on the label, any endocrinologist, scientist, GP, or high school biology student will conclude from the graphs provided in the label that superior PK/PD is obvious.
I believe that one of the post marketing studies, funded by SNY,will clear up this issue nicely.
THX Chrome and good luck!
Bio want to compare PhD's you moron
THX OPC good luck to you too.... you will eventually go long too. :) You seem too smart not to at some point. I wouldn't be surprised OPC1 I am usually a little early with my purchases, but my window is long enough that it shouldn't matter.
To be honest I am ready to ignore this for a little while, and let it ride.
I loaded my last batch today at 5.99 Time to just be patient and think in terms of my 3-5 year window. 1B in sales = a double from current levels.
I am sure we will have bumps in the road between here and there but I believe in my DD, Al Mann and this product.
Good luck to all longs!